GC CELL CORPORATION

πŸ‡°πŸ‡·South Korea
Ownership
-
Employees
-
Market Cap
-
Website

Efficacy and Safety of 'Immuncell-LC Group' and 'Non-treatment Group' in Nexavar Treated Patients for Advanced HCC

Phase 2
Completed
Conditions
Interventions
First Posted Date
2013-07-12
Last Posted Date
2023-06-26
Lead Sponsor
GC Cell Corporation
Target Recruit Count
40
Registration Number
NCT01897610
Locations
πŸ‡°πŸ‡·

Korea University Anam Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Inha University Hospital, Incheon, Korea, Republic of

πŸ‡°πŸ‡·

Yonsei University Health System, Seoul, Korea, Republic of

and more 1 locations

Long Term Follow-Up Study of Immuncell-LC Group and Non-Treatment Group in Hepatocellular Carcinoma Patients.

Completed
Conditions
First Posted Date
2013-07-01
Last Posted Date
2023-06-26
Lead Sponsor
GC Cell Corporation
Target Recruit Count
162
Registration Number
NCT01890291
Locations
πŸ‡°πŸ‡·

Seoul National Hospital, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Asan Medical Center, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Korea University Guro Hospital, Seoul, Korea, Republic of

and more 2 locations

Evaluate the Efficacy and Safety of Activated T-lymphocyte Cell Therapy in Advanced Pancreatic Cancer

Phase 2
Completed
Conditions
Interventions
First Posted Date
2009-08-26
Last Posted Date
2023-07-19
Lead Sponsor
GC Cell Corporation
Target Recruit Count
20
Registration Number
NCT00965718
Locations
πŸ‡°πŸ‡·

Yonsei medical center, Seoul, Korea, Republic of

Clinical Trial to Assess the Efficacy and Safety of 'INNOCELL Immuncell-LC' With Temozolomide in Newly Diagnosed Glioblastoma of Korea

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-12-11
Last Posted Date
2012-10-25
Lead Sponsor
GC Cell Corporation
Target Recruit Count
180
Registration Number
NCT00807027
Locations
πŸ‡°πŸ‡·

Hanyang University Guri Hospital, Guri, Gyeonggi-Do, Korea, Republic of

πŸ‡°πŸ‡·

Samsung Seoul Medical Center, Seoul, Korea, Republic of

πŸ‡°πŸ‡·

Gyunghee University Medical Center, Seoul, Korea, Republic of

and more 4 locations

Efficacy and Safety of Immuncell-LC Group and Non-treatment Group in Hepatocelluar Carcinoma Patients

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-06-18
Last Posted Date
2023-07-11
Lead Sponsor
GC Cell Corporation
Target Recruit Count
230
Registration Number
NCT00699816
Locations
πŸ‡°πŸ‡·

Korea University Guro Hospital, Seoul, Guro 2-Dong, Guro-Gu, Korea, Republic of

πŸ‡°πŸ‡·

Korea University Ansan Hospital, Ansan si, Gojan1-dong/Danwon-gu, Korea, Republic of

πŸ‡°πŸ‡·

Seoul Asan Medical center, Seoul, Pungnab2-dong/Songpa-gu, Korea, Republic of

and more 2 locations
Β© Copyright 2024. All Rights Reserved by MedPath